ARC
VIVO

Absolute Return Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Absolute Return Capital’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,027
Closed -$393K – 1422
2014
Q1 		$393K Buy
+18,027
New +$413K 0.01% 901

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Absolute Return Capital's VIVO Position: Q2 2014 in Review

Absolute Return Capital sold out of Meridian Bioscience Inc (VIVO) in Q2 2014, closing a stake of 18,027 shares — an estimated $393K sold.

Absolute Return Capital first reported a position in VIVO in Q1 2014 and held it in 1 quarter. The position peaked at $393K in Q1 2014. 161 funds tracked by Wall St. Rank hold VIVO as of Q2 2014.

  • Absolute Return Capital reported no remaining Meridian Bioscience Inc position as of Q2 2014 after selling out during the quarter.
  • Absolute Return Capital sold 18,027 Meridian Bioscience Inc shares in Q2 2014, an estimated $393K.
  • Absolute Return Capital first reported a position in Meridian Bioscience Inc in Q1 2014 and held it in 1 quarter.
  • Absolute Return Capital's Meridian Bioscience Inc position peaked at $393K in Q1 2014.
  • 161 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2014.

Based on Absolute Return Capital's 13F filing for Q2 2014, filed 14 Aug 2014.